1,755 filings
Page 30 of 88
6-K
nsgiy1l 4i1
10 Feb 15
Teva Files 2014 Annual Report on Form 20-F
12:00am
F-3ASR
pjgt1bnzpnjrof7u
9 Feb 15
Automatic shelf registration (foreign)
12:00am
6-K
fezs3syw2aogx5o7te06
5 Feb 15
Teva Reports Fourth Quarter and Full Year 2014 Results
12:00am
6-K
zjf2y4
5 Feb 15
Live Filing
12:00am
6-K
h3qfqy 5fc5gw5j1
26 Jan 15
Teva Receives Fda Approval for First Generic Nexium® Delayed-release Capsules In the United States
12:00am
6-K
4x8skx
20 Jan 15
Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE®20 mg/mL Case and Remand for Further Review
12:00am
6-K
k5ul2r7xm9qmqq4 6z
15 Jan 15
Live Filing
12:00am
6-K
54r6avtfhogmz4g41t
8 Jan 15
Teva to Present at the 33rd Annual J.P. Morgan Healthcare Conference
12:00am
6-K
juru 5i8hpn8mq
7 Jan 15
Teva Launches Generic Diovan® In the United States
12:00am
6-K
dsdqzv
23 Dec 14
Live Filing
12:00am
6-K
ds8nx9
22 Dec 14
Teva to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
12:00am
6-K
trypy
19 Dec 14
First Waterless Nasal Allergy Spray Approved for Children as Young as Four Years of Age
12:00am
6-K
u8lk3kzq0xc62w684
11 Dec 14
Teva Provides 2015 Business Outlook
12:00am
6-K
13x5v omda22oem7b
11 Dec 14
Teva Announces Launch of First Generic Celebrex® Capsules In the United States
12:00am
6-K
5ycm9l1sjq1v
4 Dec 14
Live Filing
12:00am
6-K
mckyrio5
1 Dec 14
Live Filing
12:00am
6-K
qs8kj3
1 Dec 14
Teva Announces Launch of Generic Exforge HCT® Tablets In the United States
12:00am
6-K
044ed2b
26 Nov 14
Prof. Yitzhak Peterburg Elected Chairman of Teva’s Board of Directors
12:00am
6-K
63h10 k3o
18 Nov 14
Live Filing
12:00am